Transketolase (TKT) Peptide
TKT
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN985121
Quick Overview for Transketolase (TKT) Peptide (ABIN985121)
Target
TKT
(Transketolase (TKT))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TKT antibody (Catalog #: ARP48540_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TKT (Transketolase (TKT))
-
Background
-
TKT belongs to the transketolase family. TKT has been implicated in the latent genetic disease Wernicke-Korsakoff syndrome (WKS), which causes specific brain damage.
Alias Symbols: FLJ34765, TKT1, TK
Protein Interaction Partner: MYOC,TKT,TKT
Protein Size: 623 -
Molecular Weight
- 68 kDa
-
Gene ID
- 7086
-
NCBI Accession
- NM_001064, NP_001055
-
UniProt
- P29401
Target
-
You are here:
